Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non–Small-Cell Lung Cancer: US Food and Drug Administration Trial-Level and Patient-Level Analyses

PURPOSE: To conduct analyses exploring trial-level and patient-level associations between overall response rate (ORR), progression-free survival (PFS), and overall survival (OS) in advanced non–small-cell lung cancer (NSCLC) trials. METHODS: We identified 14 trials (N = 12,567) submitted to US Food...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Blumenthal, Gideon M., Karuri, Stella W., Zhang, Hui, Zhang, Lijun, Khozin, Sean, Kazandjian, Dickran, Tang, Shenghui, Sridhara, Rajeshwari, Keegan, Patricia, Pazdur, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356710/
https://ncbi.nlm.nih.gov/pubmed/25667291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.0489
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados